Impact of CD34-positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG-based reduced intensity conditioning regimen

Am J Hematol. 2017 Apr;92(4):E57-E59. doi: 10.1002/ajh.24661. Epub 2017 Feb 24.

Authors

Aude Collignon^{1

2

3}, Boris Calmels^{4

5}, Samia Harbi¹, Sabine Fürst¹, Angela Granata¹, Catherine Faucher¹, Claude Lemarie^{4

5}, Pierre-Jean Weiller^{1

2

3}, Christian Chabannon^{4

5}, Didier Blaise^{1

2

3}, Raynier Devillier^{1

2

3}

Affiliations

¹ Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
² Medical School, Aix-Marseille University, Marseille, France.
³ Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Marseille, F-13009, France.
⁴ Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France.
⁵ CIC Biothérapies: Inserm CBT-1409, Marseille, France.

PMID: 28133837
DOI: 10.1002/ajh.24661

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Allografts
Antigens, CD34*
Antilymphocyte Serum / administration & dosage*
Female
Graft vs Host Disease / prevention & control*
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation*
Peripheral Blood Stem Cells*
Retrospective Studies
Transplantation Conditioning*

Substances

Antigens, CD34
Antilymphocyte Serum